In both CSU and RA, disease control scores positively correlated with QoL scores, meaning better disease control was associated with better QoL. Despite this correlation, 5.9% of CSU patients and 28% ...

Levels of haptoglobin in serum may help predict which patients with chronic spontaneous urticaria will achieve complete ...

- Greatly improved patient quality of life and reduced disease impact in patients with CSU and CIndU -- 82% of CSU patients reported that symptoms no longer had an impact on their quality of life at ...

Novel treatments like dupilumab, remibrutinib, and barzolvolimab show promise in treating chronic spontaneous urticaria (CSU), especially in patients resistant to standard therapies. Autoimmune CSU, ...

CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio, Inc., a leading immunotherapy company, today announced early findings from the first five recurrent glioblastoma patients treated with its ...

As chronic spontaneous urticaria (CSU) options are expanding, sustained off-treatment reductions in symptoms with the potential for drug holidays or even disease modification appear to be on the ...

- 82% of CSU patients reported that symptoms no longer had an impact on their quality of life at Week 52 - - 60% of CIndU patients reported that symptoms no longer had an impact on their quality of ...